E16.8
Other specified disorders of pancreatic internal secretion
HCC risk adjustment mapping
RxHCC V08
Pancreatic Disorders and Intestinal Malabsorption, Except Pancreatitis
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
Increased secretion from endocrine pancreas of growth hormone-releasing hormone Increased secretion from endocrine pancreas of pancreatic polypeptide Increased secretion from endocrine pancreas of somatostatin Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Official Guidelines for E16.8
FY 2026 ›Find E16.8 in the alphabetic index
6 index paths lead to this code
- Disorder › pancreatic internal secretion › specified NEC
- Hyperplasia, hyperplastic › pancreatic islet cells › alpha
- Increase, increased › secretion › pancreas, endocrine › growth hormone-releasing hormone
- Increase, increased › secretion › pancreas, endocrine › pancreatic polypeptide
- Increase, increased › secretion › pancreas, endocrine › somatostatin
- Increase, increased › secretion › pancreas, endocrine › vasoactive-intestinal polypeptide